Stockreport

Alimera Announces Reimbursement of Uveitis Indication Granted for ILUVIEN® in Portugal

Alimera Sciences, Inc.  (ALIM) 
Last alimera sciences, inc. earnings: 4/29 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.alimerasciences.com/investor-relations
PDF Reimbursement granted with no restrictions to the labelAlimera to begin selling later in Q3 ATLANTA, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: [Read more]